blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP3204507

EP3204507 - METHODS FOR DISCOVERING THERAPEUTICS THAT ALTER THE STABILITY OF TARGET PROTEINS [Right-click to bookmark this link]
StatusThe application is deemed to be withdrawn
Status updated on  06.12.2019
Database last updated on 13.11.2024
FormerExamination is in progress
Status updated on  25.01.2019
FormerRequest for examination was made
Status updated on  14.07.2017
FormerThe international publication has been made
Status updated on  12.04.2017
Most recent event   Tooltip06.12.2019Application deemed to be withdrawnpublished on 08.01.2020  [2020/02]
Applicant(s)For all designated states
Dana-Farber Cancer Institute, Inc.
450 Brookline Avenue
Boston, MA 02215 / US
[2017/33]
Inventor(s)01 / KAELIN, William
177 Commonwealth Avenue
Boston, MA 02116 / US
02 / LU, Gang
11692 Carmel Creek Road
Apt. 306
San Diego, CA 92130 / US
03 / MIDDLETON, Richard
556 Acorn Park Drive
Acton, MA 01720 / US
04 / WONG, Kowk Kin
49 Columbia Road
Arlington, MA 02474 / US
 [2017/33]
Representative(s)Williams, Gareth Owen
Marks & Clerk LLP
62-68 Hills Road
Cambridge CB2 1LA / GB
[2017/33]
Application number, filing date15848217.409.10.2015
[2017/33]
WO2015US54914
Priority number, dateUS201462062257P10.10.2014         Original published format: US 201462062257 P
[2017/33]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2016057903
Date:14.04.2016
Language:EN
[2016/15]
Type: A1 Application with search report 
No.:EP3204507
Date:16.08.2017
Language:EN
The application published by WIPO in one of the EPO official languages on 14.04.2016 takes the place of the publication of the European patent application.
[2017/33]
Search report(s)International search report - published on:US14.04.2016
(Supplementary) European search report - dispatched on:EP16.02.2018
ClassificationIPC:C12Q1/02, C12N15/64
[2018/11]
CPC:
G01N33/5023 (EP,US); C12Q1/02 (US); G01N2333/00 (US);
G01N33/68 (US)
Former IPC [2017/33]C12Q1/02
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2017/33]
TitleGerman:VERFAHREN ZUR ENTDECKUNG VON THERAPEUTIKA ZUR ÄNDERUNG DER STABILITÄT VON ZIELPROTEINEN[2017/33]
English:METHODS FOR DISCOVERING THERAPEUTICS THAT ALTER THE STABILITY OF TARGET PROTEINS[2017/33]
French:PROCÉDÉS PERMETTANT DE DÉCOUVRIR DES AGENTS THÉRAPEUTIQUES QUI MODIFIENT LA STABILITÉ DE PROTÉINES CIBLES[2017/33]
Entry into regional phase12.04.2017National basic fee paid 
12.04.2017Search fee paid 
12.04.2017Designation fee(s) paid 
12.04.2017Examination fee paid 
Examination procedure12.04.2017Examination requested  [2017/33]
12.04.2017Date on which the examining division has become responsible
14.09.2018Amendment by applicant (claims and/or description)
29.01.2019Despatch of a communication from the examining division (Time limit: M06)
09.08.2019Application deemed to be withdrawn, date of legal effect  [2020/02]
04.09.2019Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time  [2020/02]
Fees paidRenewal fee
27.10.2017Renewal fee patent year 03
29.10.2018Renewal fee patent year 04
Penalty fee
Additional fee for renewal fee
31.10.201905   M06   Not yet paid
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Cited inInternational search[Y]WO0244427  (HARVARD COLLEGE [US], et al) [Y] 1-9 * entire document *;
 [A]US2004214223  (CAO LIANGXIAN [US], et al) [A] 1-9* entire document *;
 [A]US2011191873  (STACK JEFFREY [US], et al) [A] 1-9 * entire document *;
 [A]WO2013130482  (UNIV KANSAS [US]) [A] 1-9 * entire document *;
 [Y]US8809017  (YANG YUANSHENG [SG], et al) [Y] 1-9 * entire document *
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.